OP0292 MUTATIONS IN DNASE1L3 CAUSING FAMILIAL HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS AND EARLY ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: N. Aljaberi, A. Aldhaheri, H. Alblooshi
Journal: Annals of the Rheumatic Diseases (2023)

<h3>Background</h3> Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease with several aberrancies in the immune system[1]. Genetics factors are central to understanding the pathophysiology especially in patients with monogenic lupus (single-gene mutation)[2]. Anecdotally, we observe a relatively high prevalence of familial SLE in our region (UAE/Arab regions). Studying the genetics of such cases have yielded gene mutations known to cause SLE. Here we report 3 siblings with mutations in <i>DNAES1L3</i> causing SLE and hypocomplementenemic urticarial vasculitis (HUVS)[3]. <h3>Objectives</h3> To report the clinical and genetic presentation of 3 siblings with monogenic SLE and HUVS and discuss clinicopathologic correlations. <h3>Methods</h3> The patients were identified through our SLE clinical cohort. Informed consent was obtained from the patients/guardians to participate in our institution's "Mendelian Project" research study. The study is approved by the local IRB committee. Whole exome sequencing (WES) was performed. The results of the initial sequencing were analyzed in the context of the clinical presentation of SLE and HUVS. <h3>Results</h3> Genetic analysis via WES revealed a homozygous <i>DNASE1L3</i> variant at c.572A&gt;G; p. Asn191Ser for the 3 affected siblings classified as variant of unknow significance (VUS). The mother and healthy sibling were heterozygous (carrier) for the variant. This indicate that the variant is segregating with the family for SLE. <i>DNASE1L3</i> variant c.572A&gt;G, p.Asn191Ser is a novel variant that was not reported previously in the literature or human genetic mutation database (HGMD). Computational (in-silico) pathogenicity prediction tools predicted damaging effect of the variant (PolyPhen: damaging, SIFT: Deleterious, Conservation: high). Clinical and laboratory features are presented in Table 1. All three siblings developed HUVS as the initial manifestation which was confirmed by skin biopsy. In the older siblings who eventually met the criteria for SLE, the HUVS resolved as other SLE symptoms emerged. The youngest sibling has not met criteria for SLE and only has skin involvement with debilitating HUVS (tender lesions and swollen hands/feet). This patient was found to have very low levels of C1q without anti-C1q antibodies. Screening for mutations in C1q was negative. Of note, the HUVS has been the most severe in this patient. <h3>Conclusion</h3> <i>DNASE1L3</i> genetic variants contribute to monogenic SLE. This report supports prior literature linking <i>DNAES1L3</i> deficiency to HUVS in addition to SLE. Further analysis of the effect of this variant on the immune system and link to C1q deficiency or consumption may shed light on relevant immune mechanisms related to SLE. <h3>References</h3> [1]Wu H, Zhao M, Tan L, Lu Q. The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation. Autoimmun Rev. (2016) 15:684–9 [2]Alperin JM, Ortiz-Fernández L, Sawalha AH. Monogenic Lupus: A Developing Paradigm of Disease. Front Immunol. 2018 Oct 30;9:2496. [3]Davis MD, Brewer JD: Urticarial vasculitis and hypo-complementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 2004, 24:183–213. <h3>Acknowledgements:</h3> NIL. <h3>Disclosure of Interests</h3> None Declared.